Helping the underprivileged to seeRoughly 300 million people are visually impaired—38 million of whom are blind and most of whom live in so-called developing countries. However, there are many institutions with specific campaigns aimed at eliminating preventable blindness.
In this issue
How to improve IOL power calculations in keratoconusOne source of error in IOL power calculation is the use of the classical keratometric approach for the characterisation of the corneal optics. This approach is based on the assumption of only one corneal surface and a fictitious index of refraction (keratometric index, nk) for obtaining an estimation of the corneal power (Pk). European Commission approves adalimumab for paediatric uveitis October 01, 2017By Laird HarrisonThe European Commission has approved adalimumab (Humira, AbbVie) as the first biologic treatment for chronic non-infectious anterior uveitis in paediatric patients from 2 years of age who have had an inadequate response to conventional therapy.